Given the potential hematogenous and CSF routes of disease dissemination, CSF circulating tumor cells (CTCs), circulating tumor DNA (ctDNA), CSF CEA levels and convolutional neural network (CNN) models are also being used to diagnose LM in gastric cancer, to identify LM-specific molecular features, and to quantify disease burden. This evidence concerns the gene CEACAM5 and lymphangioma.